AHR and cancer: Nevertheless, the recent study by White et al. allowed us to identify an overlooked AhR-dependent anti-cancer effect of leflunomide, and our results support the feasibility of the clinical application of leflunomide in melanoma and provide insight into leflunomide’s anti-proliferative effects.